PTPRC and posterior cortical atrophy: In this regard, from the technical point of view, El-Heliebi et al., published the feasibility and utility of in situ padlock probe technology for the analysis of AR-V7, AR-FL, and PSA expression in combination with immunostaining (panCK and CD45) in CTCs from PCA patients (50).